The enzyme responsible for the conversion of norepinephrine to epinephrine, phenylethanolamine N-methyltransferase (PNMT; E. C. 2.1.1.28), is present in the adrenal medulla 1, other chromaffin tissues, sympathetic ganglia 4, and the central nervous systemlL Immunofluorescence and radioenzymatic assays have localized PNMT in discrete brain regions including the hypothalamus 10,15. Cell bodies containing the enzyme are restricted to two cell groups in the rostral medulla of the brain stem, the ventral C1 region and the dorsal Cz region, areas which have established roles in cardiovascular regulation. The activity of non-specific N-methyltransferase is negligible in the brain stem 14. Epinephrine levels are reported to vary directly with PNMT activity in both adrenal and brainlZ, 19.
[aH]methyl-S-adenosyl-l-methionine (New England Nuclear Corp., specific activity 10.2 Ci/mmol) was used as the methyl donor together with unlabelled carrier to yield a final incubation molarity of 3 x 10 -5 M. Triplicate determinations on 50 / d aliquots were performed on all samples; homogenization volume was 100 mg/ml for brainstem and 50 mg/ml for adrenals. Proteins were measured by the method of LowrylL Numbers at the base of the bars indicate the number of rats in each group. Vertical bars give the S.E.M. Probability values were obtained from Student's t test, two tailed.
composed litters of 10. The pups assigned to the experimental group received dexamethasone indirectly, by way of steroid added to the drinking water of the dams (2 mg/l). Treatment, begun on postnatal day 2 or 3, was continued for 4 days. This method of dexamethasone delivery to suckling rats is known to be effective ~. At the time of weaning on day 25, we noted no increase in mortality in the experimental group compared to the controls. The weanling rats were group housed by sex and treatment and were sacrificed as adults at 4-5 months of age. In order to estimate maximal brain stem PNMT activity, we subjected the rats to acute stress, which as we have previously shown 2, produces an elevation in enzyme activity. The stress procedure employed consists of placing each animal on a horizontal shaker for 30 min (shaker stress) immediately prior to sacrifice. Rats were decapitated between 0930-1130 h, trunk blood collected for corticosterone determination, and the brains quickly removed and dissected on a chilled glass platform. We used a rectangular punch device (5 × 8 mm) to standardize the brain stem dissection which included the C1 and Ce cell groups in the medulla oblongata. Adrenals and the dissected brainstems were frozen in liquid nitrogen and stored for subsequent PNMT assay. The combined results of the original experiment and a replication are presented.
As adults, the earlier dexamethasone treated rats had brain stem PNMT activities 61% (P < 0.001) and 65 % (P < 0.01) higher in males and females respectively, than the controls (Fig. IA) . In contrast to this effect on brain PNMT activity, we 
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Dex Fig. 2 . Plasma of corticosterone after 30 minute shaker stress in adult rats which had I>~en treated neonatally with dexamethasone, Corticosteron¢ was assayed by a previously described competitive protein binding assay 2 modified to increase sensitivity by using only 2% corticostcroid binding globulin. Each sample extract was assayed at two doses, each in duplicate.
found that neonatal corticoid administration did not affect adrenal levels of PNMT activity in the animals as adults (Fig. 1B) . The elevated activity in brain stem PNMT was not due to altered levels of plasma corticosterone produced by the dexamethasone exposure (Fig. 2) . Glucocorticoid treatment did not produce growth retardation as judged by body weights at the time of sacrifice. Neither pituitary nor adrenal organ weights differed significantly between the groups.
These results demonstrate that maximal (poststress) PNMT activity is higher in the early dexamethasone-treated animals. Whether this represents an exaggerated stress response or a permanent elevation in enzyme activity remains to be determined. It is possible that the observed increase in enzyme activity is directly related to stress since shaker stress does produce a significant rise in brain, but not adrenal PNMT 18. However, we believe that it is more probable that this increased enzyme activity represents a chronic PNMT enhancement. Enhancement may be due to an increase in the number of enzyme molecules resulting either from cellular proliferation (such as neonatal dexamethasone produces in ganglia of the autonomic nervous system) or from actual enzyme induction (as apparently occurs in the adrenal). Elevated enzyme activity, however, could be due to a number of factors other than an increase in the number of PNMT molecules: decreased enzyme degradation; a decreased ratio of S-adenosylhomocysteine to Sadenosylmethionine6; altered substrate or product concentrationV; or an ionic strength change in the immediate environment of the enzyme 5. Elevated brain stem PNMT activity is known to have physiological significance. Increased activity has been implicated in the development of genetic hypertension 16. Experimentally hypertensive rats, which also have increased enzyme activity, show a reduction in blood pressure following the administration of a PNMT inhibitor. The participation of the epinephrine neuronal system in the stress reaction is evidenced by decreased levels of brain epinephrine and increased turnover of this neurotransmitter following footshock 17.
The present finding emphasizes the differences between the mechanisms regulating PNMT activity in the brain and in the adrenal, and suggests that the brain enzyme is more sensitive than the adrenal enzyme to changes in hormonal parameters during development. We interpret our data as suggesting that chronic early stress, through the action of glucocorticoids, may permanently augment the increased epinephrine synthesis associated with stress in the mature animal.
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